Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Gains from Investment Securities (2018 - 2025)

TELA Bio (TELA) has 8 years of Gains from Investment Securities data on record, last reported at $35304.0 in Q2 2025.

  • For Q2 2025, Gains from Investment Securities fell 75.62% year-over-year to $35304.0; the TTM value through Jun 2025 reached $35304.0, down 75.62%, while the annual FY2024 figure was $2.1 million, 2.0% down from the prior year.
  • Gains from Investment Securities reached $35304.0 in Q2 2025 per TELA's latest filing, down from $2.5 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $2.5 million in Q1 2025 and bottomed at -$1.2 million in Q4 2022.
  • Average Gains from Investment Securities over 5 years is $669962.9, with a median of $175978.0 recorded in 2021.
  • Peak YoY movement for Gains from Investment Securities: tumbled 171.44% in 2022, then soared 52879.58% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at $1.7 million in 2021, then tumbled by 171.44% to -$1.2 million in 2022, then soared by 100.33% to $4000.0 in 2023, then skyrocketed by 52879.58% to $2.1 million in 2024, then crashed by 98.33% to $35304.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were $35304.0 in Q2 2025, $2.5 million in Q1 2025, and $2.1 million in Q4 2024.